Aryx Therapeutics Stock Future Price Prediction


USD 0.0005  0.00  0.00%   

Aryx Therapeutics stock price prediction is an act of determining the future value of Aryx Therapeutics shares using few different conventional methods such as EPS estimation, analyst consensus, or fundamental intrinsic valuation. The successful prediction of Aryx Therapeutics' future price could yield a significant profit. Please, note that this module is not intended to be used solely to calculate an intrinsic value of Aryx Therapeutics and does not consider all of the tangible or intangible factors available from Aryx Therapeutics' fundamental data. We analyze noise-free headlines and recent hype associated with Aryx Therapeutics, which may create opportunities for some arbitrage if properly timed.
Please continue to Aryx Therapeutics Basic Forecasting Models to cross-verify your projections.
It is a matter of debate whether stock price prediction based on information in financial news can generate a strong buy or sell signal. We use our internally-built news screening methodology to estimate the value of Aryx Therapeutics based on different types of headlines from major news networks to social media. The Aryx Therapeutics stock price prediction module provides an analysis of price elasticity to changes in media outlook on Aryx Therapeutics over a specific investment horizon.
Wall Street Target Price
Using Aryx Therapeutics hype-based prediction, you can estimate the value of Aryx Therapeutics from the perspective of Aryx Therapeutics response to recently generated media hype and the effects of current headlines on its competitors.
Aryx Therapeutics Current Ratio is fairly stable at the moment as compared to the past year. Aryx Therapeutics reported Current Ratio of 1.17 in 2021. Price to Sales Ratio is likely to rise to 4.30 in 2022, whereas Asset Turnover is likely to drop 0.27 in 2022.
This module is based on analyzing investor sentiment around taking a position in Aryx Therapeutics. This speculative approach is based exclusively on the idea that markets are driven by emotions such as investor fear and greed. The fear of missing out, i.e., FOMO, can cause potential investors in Aryx Therapeutics to buy its stock at a price that has no basis in reality. In that case, they are not buying Aryx Therapeutics because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.

Aryx Therapeutics after-hype prediction price

  $ 5.34E-4  
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Sophisticated investors, who have witnessed many market ups and downs, frequently view the market will even out over time. This tendency of Aryx Therapeutics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy. Please use the tools below to analyze the current value of Aryx Therapeutics in the context of predictive analytics.
LowReal ValueHigh
LowNext ValueHigh
Band Projection (param)
LowerMiddle BandUpper
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Aryx Therapeutics. Your research has to be compared to or analyzed against Aryx Therapeutics' peers to derive any actionable benefits. When done correctly, Aryx Therapeutics' competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy towards taking a position in Aryx Therapeutics.

Aryx Therapeutics After-Hype Price Prediction Density Analysis

As far as predicting the price of Aryx Therapeutics at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Aryx Therapeutics or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many smart people who confused the symmetrical distributions of stock prices, such as prices of Aryx Therapeutics, with the unreliable approximations that try to describe financial returns.
   Next price density   
       Expected price to next headline  

Aryx Therapeutics Estimiated After-Hype Price Volatility

In the context of predicting Aryx Therapeutics' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Aryx Therapeutics' historical news coverage. Aryx Therapeutics' after-hype downside and upside margins for the prediction period are 0.00 and 5.25, respectively. We have considered Aryx Therapeutics' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value 0.0005
After-hype Price
Aryx Therapeutics is out of control asset. Analysis and calculation of next after-hype price of Aryx Therapeutics is based on 3 months time horizon.

Aryx Therapeutics Stock Price Prediction Analysis

Have you ever been surprised when a price of a company such as Aryx Therapeutics is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Aryx Therapeutics backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Aryx Therapeutics, there might be something going there, and it might present an excellent short sale opportunity.
Expected ReturnPeriod VolatilityHype ElasticityRelated ElasticityNews DensityRelated DensityExpected Hype
 0.94  5.25  0.00   0.59  0 Events / Month1 Events / MonthIn 5 to 10 days
Latest traded priceExpected after-news pricePotential return on next major newsAverage after-hype volatility

Aryx Therapeutics Hype Timeline

Aryx Therapeutics is presently traded for 0.0005. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.59. Aryx Therapeutics is anticipated to increase in value after the next headline with price projected to jump to 5.34E-4 or above. The average volatility of media hype impact on the company stock price is about 0.0%. The price jump on the next news is forecasted to be 6.83% whereas the daily expected return is presently at 0.94%. The volatility of related hype on Aryx Therapeutics is about 833.33% with expected price after next announcement by competition of 0.59. Given the investment horizon of 90 days the next anticipatedpress releasewill be in 5 to 10 days.
Please continue to Aryx Therapeutics Basic Forecasting Models to cross-verify your projections.

Aryx Therapeutics Related Hype Analysis

Having access to credible news sources related to Aryx Therapeutics' direct competition is more important than ever and may enhance your ability to predict Aryx Therapeutics' future price movements. Getting to know how Aryx Therapeutics rivals react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Aryx Therapeutics may potentially react to the hype associated with one of its peers.
At Risk
LZBLa-Z-Boy 0.63 7 per month 2.33  0.06  3.67 (4.47)  13.54 

Aryx Therapeutics Additional Predictive Modules

Most predictive techniques to examine Aryx Therapeutics price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Aryx Therapeutics using various technical indicators. When you analyze Aryx Therapeutics charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About Aryx Therapeutics Predictive Indicators

The successful prediction of Aryx Therapeutics stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Aryx Therapeutics, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Aryx Therapeutics based on analysis of Aryx Therapeutics hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Aryx Therapeutics's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Aryx Therapeutics's related companies.

Story Coverage note for Aryx Therapeutics

The number of cover stories for Aryx Therapeutics depends on current market conditions and Aryx Therapeutics' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Aryx Therapeutics is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Aryx Therapeutics' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.

Aryx Therapeutics Short Properties

Aryx Therapeutics' future price predictability will typically decrease when Aryx Therapeutics' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Aryx Therapeutics often depends not only on the future outlook of the potential Aryx Therapeutics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Aryx Therapeutics' indicators that are reflective of the short sentiment are summarized in the table below.
Shares Percent Shares Out0.27%
Shares Short Prior Month95.84k
Average Daily Volume In Three Month226
Date Short Interest28th of February 2011
Please continue to Aryx Therapeutics Basic Forecasting Models to cross-verify your projections. Note that the Aryx Therapeutics information on this page should be used as a complementary analysis to other Aryx Therapeutics' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.

Complementary Tools for Aryx Therapeutics Stock analysis

When running Aryx Therapeutics price analysis, check to measure Aryx Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Aryx Therapeutics is operating at the current time. Most of Aryx Therapeutics' value examination focuses on studying past and present price action to predict the probability of Aryx Therapeutics' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Aryx Therapeutics' price. Additionally, you may evaluate how the addition of Aryx Therapeutics to your portfolios can decrease your overall portfolio volatility.
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
ETF Directory
Find actively traded Exchange Traded Funds (ETF) from around the world
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Is Aryx Therapeutics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Aryx Therapeutics. If investors know Aryx Therapeutics will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Aryx Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Market Capitalization
237.6 K
Return On Assets
The market value of Aryx Therapeutics is measured differently than its book value, which is the value of Aryx Therapeutics that is recorded on the company's balance sheet. Investors also form their own opinion of Aryx Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Aryx Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Aryx Therapeutics' market value can be influenced by many factors that don't directly affect Aryx Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Aryx Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine Aryx Therapeutics value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Aryx Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.